AR027240A1 - Combinacion de mirtazapina y gepirona para el tratamiento de la depresion y trastornos relacionados - Google Patents
Combinacion de mirtazapina y gepirona para el tratamiento de la depresion y trastornos relacionadosInfo
- Publication number
- AR027240A1 AR027240A1 ARP010100214A ARP010100214A AR027240A1 AR 027240 A1 AR027240 A1 AR 027240A1 AR P010100214 A ARP010100214 A AR P010100214A AR P010100214 A ARP010100214 A AR P010100214A AR 027240 A1 AR027240 A1 AR 027240A1
- Authority
- AR
- Argentina
- Prior art keywords
- mirtazapine
- combination
- related disorders
- depression
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Una combinacion que comprende una cantidad de mirtazapina o una sal o solvato farmacéuticamente aceptable de la misma, y una cantidad de gepirona o una salo solvato farmacéuticamente aceptable de la misma, opcionalmente en asociacion con uno o más ve hículos farmacéuticamente aceptables, donde la cantidad degepirona y la cantidad de mirtazapina son tales que el efecto de la composicion es más favorable que los efectos sumados de las cantidades de cada fármaco porseparado. Esta combinacion puede u sarse en el tratamiento de la depresion y trastornos relacionados, por lo cual también se proporciona un nuevo método detratamiento de la depresion y trastornos relacionados.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00200189 | 2000-01-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR027240A1 true AR027240A1 (es) | 2003-03-19 |
Family
ID=8170928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010100214A AR027240A1 (es) | 2000-01-19 | 2001-01-18 | Combinacion de mirtazapina y gepirona para el tratamiento de la depresion y trastornos relacionados |
Country Status (21)
Country | Link |
---|---|
US (2) | US6835728B2 (es) |
EP (1) | EP1251854A2 (es) |
JP (1) | JP2003520237A (es) |
KR (1) | KR20020068404A (es) |
CN (1) | CN1223349C (es) |
AR (1) | AR027240A1 (es) |
AU (1) | AU780817B2 (es) |
BR (1) | BR0107721A (es) |
CA (1) | CA2396066A1 (es) |
CO (1) | CO5261583A1 (es) |
HK (1) | HK1047548A1 (es) |
HU (1) | HUP0204050A3 (es) |
IL (1) | IL150289A0 (es) |
MX (1) | MXPA02007095A (es) |
NO (1) | NO20023448L (es) |
PE (1) | PE20011049A1 (es) |
PL (1) | PL356605A1 (es) |
RU (1) | RU2268725C2 (es) |
SK (1) | SK10552002A3 (es) |
WO (1) | WO2001052855A2 (es) |
ZA (1) | ZA200205161B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7053092B2 (en) | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
US20060039867A1 (en) * | 2004-08-20 | 2006-02-23 | Cypress Bioscience, Inc. | Method for treating sleep-related breathing disorders with setiptiline |
US20060122127A1 (en) * | 2004-11-17 | 2006-06-08 | Cypress Bioscience, Inc. | Methods for reducing the side effects associated with mirtzapine treatment |
GT200600414A (es) | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
TW200800306A (en) | 2005-09-12 | 2008-01-01 | Wyeth Corp | Sustained-release formulation and uses thereof |
GT200600416A (es) | 2005-09-12 | 2007-09-20 | Sales salicilato y gentisato de un compuesto de piperazina | |
EP1792618A1 (en) * | 2005-11-30 | 2007-06-06 | Rainer Freynhagen | R-mirtazapine for the treatment of pain |
TW200808804A (en) * | 2006-05-22 | 2008-02-16 | Organon Nv | Mirtazapine for the treatment of neuropathic pain |
KR20090024140A (ko) * | 2006-05-22 | 2009-03-06 | 반다 파마슈티칼즈, 인코퍼레이티드. | 우울증 질환에 대한 치료 |
EP2167096A4 (en) * | 2007-06-13 | 2010-07-14 | Cypress Bioscience Inc | IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM |
KR20100094495A (ko) * | 2007-11-02 | 2010-08-26 | 애크럭스 디디에스 피티와이 리미티드 | 호르몬 및 스테로이드를 위한 경피 전달 시스템 |
US20130064770A1 (en) | 2010-05-28 | 2013-03-14 | Ge Healthcare Limited | Radiolabeled compounds and methods thereof |
GB201112987D0 (en) | 2011-07-28 | 2011-09-14 | Ge Healthcare Ltd | Novel compound |
CN108743593B (zh) * | 2018-08-31 | 2019-03-26 | 程世宏 | 一种抗抑郁药物及其口服颗粒剂和制药用途 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
US4771053A (en) * | 1987-03-02 | 1988-09-13 | Bristol-Myers Company | Method for alleviation of primary depressive disorders |
US5114976A (en) * | 1989-01-06 | 1992-05-19 | Norden Michael J | Method for treating certain psychiatric disorders and certain psychiatric symptoms |
US5011841B1 (en) * | 1989-11-14 | 1994-09-06 | Pfizer | Treatment of depression |
GB9303968D0 (en) | 1993-02-26 | 1993-04-14 | Wyeth John & Brother Ltd | 5-ht1a ligands |
GB9603136D0 (en) * | 1996-02-15 | 1996-04-17 | Merck Sharp & Dohme | Therapeutic agents |
IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
ZA982368B (en) * | 1997-03-27 | 1998-09-23 | Akzo Nobel Nv | New therapeutic combinations |
IL123716A (en) * | 1997-03-27 | 2001-03-19 | Akzo Nobel Nv | Therapeutic combinations of mirtazapine and an antipsychotic agent |
-
2001
- 2001-01-15 RU RU2002122084/15A patent/RU2268725C2/ru not_active IP Right Cessation
- 2001-01-15 JP JP2001552902A patent/JP2003520237A/ja not_active Withdrawn
- 2001-01-15 KR KR1020027009276A patent/KR20020068404A/ko not_active Application Discontinuation
- 2001-01-15 AU AU25162/01A patent/AU780817B2/en not_active Ceased
- 2001-01-15 IL IL15028901A patent/IL150289A0/xx unknown
- 2001-01-15 US US10/181,843 patent/US6835728B2/en not_active Expired - Fee Related
- 2001-01-15 EP EP01900449A patent/EP1251854A2/en not_active Withdrawn
- 2001-01-15 WO PCT/EP2001/000407 patent/WO2001052855A2/en not_active Application Discontinuation
- 2001-01-15 CN CNB018038654A patent/CN1223349C/zh not_active Expired - Fee Related
- 2001-01-15 HU HU0204050A patent/HUP0204050A3/hu unknown
- 2001-01-15 BR BR0107721-0A patent/BR0107721A/pt not_active IP Right Cessation
- 2001-01-15 MX MXPA02007095A patent/MXPA02007095A/es not_active Application Discontinuation
- 2001-01-15 CA CA002396066A patent/CA2396066A1/en not_active Abandoned
- 2001-01-15 PL PL01356605A patent/PL356605A1/xx not_active Application Discontinuation
- 2001-01-15 SK SK1055-2002A patent/SK10552002A3/sk not_active Application Discontinuation
- 2001-01-18 CO CO01003479A patent/CO5261583A1/es not_active Application Discontinuation
- 2001-01-18 AR ARP010100214A patent/AR027240A1/es not_active Application Discontinuation
- 2001-01-18 PE PE2001000055A patent/PE20011049A1/es not_active Application Discontinuation
-
2002
- 2002-06-27 ZA ZA200205161A patent/ZA200205161B/en unknown
- 2002-07-18 NO NO20023448A patent/NO20023448L/no not_active Application Discontinuation
- 2002-12-18 HK HK02109168.5A patent/HK1047548A1/zh unknown
-
2004
- 2004-11-22 US US10/996,213 patent/US20050090488A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2396066A1 (en) | 2001-07-26 |
NO20023448D0 (no) | 2002-07-18 |
WO2001052855A3 (en) | 2002-01-10 |
SK10552002A3 (sk) | 2002-12-03 |
KR20020068404A (ko) | 2002-08-27 |
HK1047548A1 (zh) | 2003-02-28 |
AU2516201A (en) | 2001-07-31 |
PL356605A1 (en) | 2004-06-28 |
BR0107721A (pt) | 2002-10-01 |
NO20023448L (no) | 2002-09-17 |
CO5261583A1 (es) | 2003-03-31 |
AU780817B2 (en) | 2005-04-21 |
US20050090488A1 (en) | 2005-04-28 |
MXPA02007095A (es) | 2003-04-14 |
ZA200205161B (en) | 2003-09-29 |
US6835728B2 (en) | 2004-12-28 |
US20030105083A1 (en) | 2003-06-05 |
EP1251854A2 (en) | 2002-10-30 |
PE20011049A1 (es) | 2001-10-18 |
WO2001052855A2 (en) | 2001-07-26 |
HUP0204050A2 (hu) | 2003-03-28 |
IL150289A0 (en) | 2002-12-01 |
RU2002122084A (ru) | 2004-03-10 |
HUP0204050A3 (en) | 2004-09-28 |
JP2003520237A (ja) | 2003-07-02 |
WO2001052855A8 (en) | 2002-12-27 |
CN1223349C (zh) | 2005-10-19 |
CN1395486A (zh) | 2003-02-05 |
RU2268725C2 (ru) | 2006-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR027240A1 (es) | Combinacion de mirtazapina y gepirona para el tratamiento de la depresion y trastornos relacionados | |
AR047841A1 (es) | Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios | |
NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
AR034746A1 (es) | Combinaciones para el tratamiento de trastornos inflamatorios | |
FR2869231B1 (fr) | Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine | |
AR054094A1 (es) | Tratamientos de cancer | |
DE602004031462D1 (de) | Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung | |
AR052774A1 (es) | Inmunoterapia para trastornos autoinmunes | |
BRPI0517481A (pt) | método para tratar, controlar ou evitar uma doença ou distúrbio parasìtico protozoário, e, composição farmacêutica | |
AR048502A1 (es) | Sinergia terapeutica de compuestos anti-cancer | |
DK1401458T3 (da) | Sammensætning bestående af PHY906 og kemoterapeutiske midler | |
AR034900A1 (es) | Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica | |
AR052830A1 (es) | Regimen de cladribina para tratar esclerosis multiple | |
EP1503748A4 (en) | DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY | |
ATE319479T1 (de) | Verfahren zur erhöhen der bioverfügbarkeit und dem eindringen in gefässe von azithromycin | |
SV2008002856A (es) | 2-amino-7, 8-dihidro-6h-pirido [4,3-d] pirimidina-5-onas | |
ATE399558T1 (de) | Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln | |
ATE244010T1 (de) | Arzneistoffkombination zur behandlung von kopfschmerzen mit mirtazapine und paracetamol oder nicht-steroiden entzündungshemmenden mitteln | |
MXPA04002553A (es) | El uso de vitamina b6 para mitigar defectos de campo visual asociados con el uso de farmacos gabaergicos en mamiferos. | |
WO2006036956A3 (en) | Therapeutic regimen for treating cancer using quassinoids and other chemotherapeutic agents | |
AR026756A1 (es) | Nuevas combinaciones terapeuticas (s)-2-bencilamino-metil)-2,3,8,9-tetrahidro-7h-1,4-dioxino[2,3-e]indol-8-ona y neuroleticos para el tratamiento oprevencion de desordenes psicoticos | |
MXPA04005097A (es) | Composicion y metodo para tratar el rechazo cronico de aloinjertos. | |
BRPI0517847A (pt) | combinação, usos de um inibidor de reabsorção de serotonina seletiva e de um antagonista do receptor de glicocorticóide, e, método para o tratamento de um indivìduo de uma espécie vertebrada sofrendo de depressão ou um distúrbio relacionado | |
AR012187A1 (es) | Composicion farmaceutica libre de lactosa que contiene noratemizol como agente activo, formas de dosificacion que contiene dicha composicion y metodopara el tratamiento de desordenes alergicos con aplicacion de dicha composicion | |
AR027037A1 (es) | Compusto y metodo para el tratamiento del dolor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |